Nanoveu Limited
NNVUF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.09 | 0.13 | 0.14 | 0.52 |
| FCF Yield | -20.86% | -18.19% | -28.21% | -42.67% |
| EV / EBITDA | -5.00 | -5.64 | -2.89 | -2.09 |
| Quality | ||||
| ROIC | -606.09% | -3,671.98% | -815.32% | -68.72% |
| Gross Margin | 153.21% | 24.64% | 17.15% | 43.03% |
| Cash Conversion Ratio | – | 0.93 | 0.70 | 0.88 |
| Growth | ||||
| Revenue 3-Year CAGR | -60.16% | -50.23% | -27.38% | 136.41% |
| Free Cash Flow Growth | -34.92% | -5.08% | 12.22% | 15.40% |
| Safety | ||||
| Net Debt / EBITDA | 0.22 | -0.06 | -0.08 | 0.33 |
| Interest Coverage | -492.65 | -99.81 | -14.16 | -6.79 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.95 |
| Cash Conversion Cycle | 44,048.29 | -319.25 | -217.05 | 375.95 |